Kontafarma China Holdings Limited (HKG:1312)

Kontafarma China Holdings Statistics

Total Valuation

HKG:1312 has a market cap or net worth of HKD 173.25 million. The enterprise value is 266.70 million.

Market Cap	173.25M
Enterprise Value	266.70M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1312 has 5.59 billion shares outstanding.

Current Share Class	5.59B
Shares Outstanding	5.59B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.90B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.19
PB Ratio	0.28
P/TBV Ratio	0.41
P/FCF Ratio	5.39
P/OCF Ratio	3.49
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.17, with an EV/FCF ratio of 8.30.

EV / Earnings	-0.74
EV / Sales	0.30
EV / EBITDA	12.17
EV / EBIT	n/a
EV / FCF	8.30

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.38.

Current Ratio	1.02
Quick Ratio	0.79
Debt / Equity	0.38
Debt / EBITDA	10.77
Debt / FCF	7.34
Interest Coverage	-6.02

Financial Efficiency

Return on equity (ROE) is -49.47% and return on invested capital (ROIC) is -9.66%.

Return on Equity (ROE)	-49.47%
Return on Assets (ROA)	-3.31%
Return on Invested Capital (ROIC)	-9.66%
Return on Capital Employed (ROCE)	-10.20%
Weighted Average Cost of Capital (WACC)	4.14%
Revenue Per Employee	1.36M
Profits Per Employee	-553,841
Employee Count	655
Asset Turnover	0.63
Inventory Turnover	4.43

Taxes

Income Tax	-24.99M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-0.03
52-Week Price Change	n/a
50-Day Moving Average	0.03
200-Day Moving Average	0.03
Relative Strength Index (RSI)	57.03
Average Volume (20 Days)	650,100

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1312 had revenue of HKD 891.73 million and -362.77 million in losses. Loss per share was -0.07.

Revenue	891.73M
Gross Profit	493.63M
Operating Income	-75.23M
Pretax Income	-440.90M
Net Income	-362.77M
EBITDA	-40.22M
EBIT	-75.23M
Loss Per Share	-0.07

Balance Sheet

The company has 78.33 million in cash and 235.86 million in debt, with a net cash position of -157.53 million or -0.03 per share.

Cash & Cash Equivalents	78.33M
Total Debt	235.86M
Net Cash	-157.53M
Net Cash Per Share	-0.03
Equity (Book Value)	620.92M
Book Value Per Share	0.12
Working Capital	6.98M

Cash Flow

In the last 12 months, operating cash flow was 49.63 million and capital expenditures -17.49 million, giving a free cash flow of 32.13 million.

Operating Cash Flow	49.63M
Capital Expenditures	-17.49M
Free Cash Flow	32.13M
FCF Per Share	0.01

Margins

Gross margin is 55.36%, with operating and profit margins of -8.44% and -40.68%.

Gross Margin	55.36%
Operating Margin	-8.44%
Pretax Margin	-49.44%
Profit Margin	-40.68%
EBITDA Margin	-4.51%
EBIT Margin	-8.44%
FCF Margin	3.60%

Dividends & Yields

HKG:1312 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-209.39%
FCF Yield	18.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 20, 2015. It was a forward split with a ratio of 5.

Last Split Date	Jan 20, 2015
Split Type	Forward
Split Ratio	5

Scores

HKG:1312 has an Altman Z-Score of 0.25 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.25
Piotroski F-Score	3